phone Contact Us

Company Updates

Opharmic Announces Office Relocation Within HKSTP

Graduation of HKSTP Incu-Bio Programme

Hong Kong, 15 January 2020

Opharmic Technology (HK) Limited is pleased to announce its office relocation within the Hong Kong Science and Technology Parks (HKSTP). Following the successful graduation from the HKSTP Incu-Bio Programme in late 2019, the company has transitioned to a new space while remaining part of the prestigious HKSTP community as a tenant.

This strategic move provides Opharmic with enhanced facilities to support its growing team and accelerating research and development activities. The new office space is designed to foster collaboration and innovation as the company advances its proprietary ultrasound platform.

Opharmic continues to focus on developing non-invasive ultrasound technologies that address significant unmet needs. MeticTouch® aims to revolutionize ocular drug delivery by improving permeability in a targeted, non-invasive manner.

"The relocation within HKSTP allows us to maintain close ties with the vibrant innovation ecosystem while gaining the infrastructure needed for our next phase of growth," said Sarah Cheung, VP, Operations of Opharmic Technology. "We are excited to continue building on the strong foundation established during our incubation period."

The move underscores Opharmic’s commitment to operational excellence and long-term development in Hong Kong’s thriving medtech sector. The company remains dedicated to its mission of creating patient-friendly solutions that enhance therapeutic outcomes.

Author

Opharmic Technology